Edap TMSFOCL +1.91%53 FCF Margin % is -21.90% as of Mar. 2026. GuruFocus rates FOCL with a GF Score™ of 53/100 and a GF Value™ of $4.52 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 118 Medical Distribution companies, Edap TMS ranks worse than 90.68% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Edap TMS's Free Cash Flow for the
three
months ended in Mar. 2026 was $-3.9 Mil. Edap TMS's Revenue for the
three
months ended in Mar. 2026 was $17.8 Mil. Therefore, Edap TMS's FCF Margin % for the quarter that ended in Mar. 2026 was -21.90%.
The historical rank and industry rank for Edap TMS's FCF Margin % or its related term are showing as below:
FOCL'
s FCF Margin % Range Over the Past 10 Years
Min: -31.43 Med: -7.01 Max: 6.35
Current: -18.68
During the past 13 years, the highest FCF Margin % of Edap TMS was 6.35%. The lowest was -31.43%. And the median was -7.01%.
FOCL's FCF Margin % is ranked worse than 90.68% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs FOCL: -18.68
Edap TMS FCF Margin % Related Terms
Edap TMS FCF Margin % Historical Data
* Premium members only.
The historical data trend for Edap TMS's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Edap TMS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edap TMS FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Edap TMS's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Edap TMS's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edap TMS (FOCL) has a FCF Margin % of -21.90% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Edap TMS and its competitors. According to the industry distribution chart, Edap TMS ranks #107 out of 118 companies in the Medical Distribution industry, placing it in the top 90.7%.
Is Edap TMS's FCF Margin % too high?
Edap TMS's current FCF Margin % is -21.90%. Based on the distribution chart, Edap TMS ranks #107 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Edap TMS has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Edap TMS's FCF Margin % compare to ACH and YI?
According to the Medical Distribution industry distribution chart, Edap TMS ranks #107 out of 118 companies for FCF Margin %. This places Edap TMS in the lower half of its industry. The industry median FCF Margin % is 1.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Edap TMS and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edap TMS's current FCF Margin % is -21.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edap TMS stock overvalued right now?
Based on GuruFocus' analysis, Edap TMS (FOCL) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $5.08 — trading 12.3% above its estimated fair value. The current FCF Margin % is -21.90%. Edap TMS's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Edap TMS (FOCL), the current FCF Margin % is -21.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edap TMS (FOCL) Overvalued in 2026?
Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued.
The current stock price of $5.08 is trading 12.3% above its estimated GF Value™ of $4.52.
GuruFocus considers Edap TMS to be Modestly Overvalued.
Key valuation signals for FOCL:
FCF Margin %: -21.90%
GF Value™: $4.52 vs. price of $5.08 (12.3% above fair value)
No single metric tells the full story. See the FOCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
53GF Score
Get the complete analysis for FOCL
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOCL has been successfully added to your 
